other material
confidence high
sentiment neutral
materiality 0.25
MiNK Therapeutics files amended charter post-IPO, authorizing 150M common and 5M preferred shares
MiNK Therapeutics, Inc.
- Amended charter and bylaws became effective upon IPO closing on October 19, 2021.
- Authorized capital: 150,000,000 shares of common stock, par value $0.00001 per share.
- Authorized capital includes 5,000,000 shares of preferred stock.
- Charter and bylaws are in the form previously filed with the Registration Statement on Form S-1.
- No other material modifications to security holder rights were reported.